Ling Xu

10PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Aerodynamics (excl. hypersonic aerodynamics)Haematological tumoursWater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 24, 2025
POSTN+ CAF-Derived Migrasomes Drive Hepatocellular Carcinoma Progression and Confer Resistance to Immunotherapy.

Zhenhua Zhu, Kangnan Zhang, Wei Wu

|Jun 23, 2025
CD74 Blockade Disrupts Endothelial Migrasome Signaling to Prevent Inflammatory Macrophage Differentiation and Inhibit Atherosclerotic Progression.

Kangnan Zhang, Jiong Chen, Zhenhua Zhu

|Aug 18, 2024
Metabolic dysregulation-triggered neutrophil extracellular traps exacerbate acute liver failure.

Kangnan Zhang, Rongrong Jia, Qinghui Zhang

|Jun 05, 2024
CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis.

Kangnan Zhang, Zhenhua Zhu, Rongrong Jia

|Jan 18, 2023
Antagonizing EZH2 combined with vitamin D3 exerts a synergistic role in anti-fibrosis through bidirectional effects on hepatocytes and hepatic stellate cells.

Qinghui Zhang, Rongrong Jia, Minjie Chen

|Feb 06, 2020
Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-γ Pathway.

Shihao Xiang, Kan Chen, Ling Xu

Pageof 2

Frequent Collaborators

3 joint publications

Kan Chen

2 joint publications

Yujing Xia

2 joint publications

Chuanyong Guo

1 joint publications

Chengfen Wang